RE: French trial of Toraymyxin"However, the studies conducted either include only a limited number ofpatients or are not randomized prospective studies. The post-hocanalysis of a recent randomized study conducted on a limited number ofpatients with abdominal septic shock shows a significant reduction inmortality after factor adjustment. Though the side effects of such atreatment are limited, its cost is high. Hence, extensive prospectivestudies are necessary to confirm its effectiveness."
Wonder what is meant by high cost? When it comes to saving lives what is too much?